Liver Function tests are group of tests ordered to understand how well the Liver is performing Liver Function Test-3, also known as a Liver Screen, is a group of tests that are performed together to evaluate the health of the liver. These tests typically measure the levels of certain enzymes and proteins in the blood that are associated with liver function. These tests can be used to detect liver damage, inflammation, or infection, monitor the progression of liver disease, and evaluate the effectiveness of treatment. Associated Tests: L0079 Liver Function Test-1 (Maxi) L0080 Liver Function Test-2 (Mini)

The liver plays a crucial role in overall health, performing functions such as detoxification, metabolism, and nutrient storage. It filters blood, produces bile, and supports digestion. Maintaining liver health is vital for optimal well-being and metabolic balance.

The liver is the second largest organ after the skin. It lies in the right upper abdomen below the right lung. The main two functions of the liver include - detoxification of your body and digestion of the food you consume. Liver function tests (LFT) are done to detect liver disease and assess improvement with treatment. It measures enzymes, and proteins produced by the liver and also assesses its ability to clear bilirubin. This test helps doctors understand the extent of liver disease, liver damage, and associated disorders. The Liver Function Maxi test measures the following parameters: Bilirubin (Direct): It is a liver enzyme marker. This red-orange colour pigment undergoes chemical changes in the liver. It gets transferred to the intestines to be removed through the stools. Bilirubin (Total): This test measures the total amount of Bilirubin in the blood. It measures both Direct Bilirubin and Indirect Bilirubin. Indirect Bilirubin comes from the breakdown of red blood cells. It travels in the blood to the liver. AST: Aspartate transaminase, formerly known as SGOT, or Serum glutamic-oxaloacetic transaminase, is one of the two liver enzymes. ALT: Alanine transaminase, formerly known as SGPT, or Serum glutamic-pyruvate transaminase, is one of the two liver enzymes. Total Proteins: Proteins make up the skeleton of the whole body. The two kinds of proteins in the body are Albumin and Globulin. Albumin: It is a protein made in the liver. It checks the condition of your liver and kidneys. ALP: Alkaline phosphatase is an enzyme in the blood. It helps in protein breakdown.

Liver cancer is cancer of the liver cells (hepatocytes). Hence, it is also known as Hepatocellular cancer. The diagnosis is often by cancer marker tests. Cancer markers or tumour markers are proteins produced by the normal cells as well as cancer cells, but are produced in higher levels by the cancer cells. Cancer marker Profile Liver-2 consists of tests to measure the levels of tumour markers in the blood, urine, and other body fluids. This profile test is used with other tests to screen for liver cancer and decide the best treatment.

Liver Kidney Microsome 1 antibodies are autoantibodies produced against the liver cells, that if present may lead to type 2 autoimmune hepatitis or chronic liver disease. This may lead to liver cirrhosis and even liver failure.

Includes ASMA, LKM1, ANA Autoimmune liver disease refers to a group of disorders in which the immune system mistakenly attacks the liver. This results in inflammation and damage to the liver cells, leading to various degrees of liver injury. There are several types of autoimmune liver disease, the most common types are: Autoimmune hepatitis (AIH): It is characterized by inflammation and destruction of liver cells, resulting in cirrhosis, jaundice, fatigue, abdominal pain and itchy skin. Primary biliary cholangitis (PBC): it is a chronic disease characterized by inflammation and damage of the small bile ducts within the liver. This results in the obstruction of bile flow and eventually leads to cirrhosis, jaundice and itching. Primary sclerosing cholangitis (PSC): It is characterized by inflammation and scarring of the bile ducts, both inside and outside the liver, leading to bile duct obstruction, which can result in cirrhosis, jaundice, and itching.

Includes AMA M2, M2-3E (Bpo), Sp100, PML, gp210, LKM1, LC1, SLA / LP, Ro52. Autoimmune liver disease refers to a group of disorders in which the immune system mistakenly attacks the liver. This results in inflammation and damage to the liver cells, leading to various degrees of liver injury. There are several types of autoimmune liver disease, the most common types are: Autoimmune hepatitis (AIH): It is characterized by inflammation and destruction of liver cells, resulting in cirrhosis, jaundice, fatigue, abdominal pain and itchy skin. Primary biliary cholangitis (PBC): it is a chronic disease characterized by inflammation and damage of the small bile ducts within the liver. This results in the obstruction of bile flow and eventually leads to cirrhosis, jaundice and itching. Primary sclerosing cholangitis (PSC): It is characterized by inflammation and scarring of the bile ducts, both inside and outside the liver, leading to bile duct obstruction, which can result in cirrhosis, jaundice, and itching.

Autoimmune Liver Disease Profile 1 /Autoimmune hepatitis 1 contains ANA, ASMA, LKM1, AMA which Facilitate early diagnosis of autoimmune hepatitis & Primary Biliary Cirrhosis Autoimmune liver disease refers to a group of disorders in which the immune system mistakenly attacks the liver. This results in inflammation and damage to the liver cells, leading to various degrees of liver injury. There are several types of autoimmune liver disease, the most common types are: Autoimmune hepatitis (AIH): It is characterized by inflammation and destruction of liver cells, resulting in cirrhosis, jaundice, fatigue, abdominal pain and itchy skin. Primary biliary cholangitis (PBC): it is a chronic disease characterized by inflammation and damage of the small bile ducts within the liver. This results in the obstruction of bile flow and eventually leads to cirrhosis, jaundice and itching. Primary sclerosing cholangitis (PSC): It is characterized by inflammation and scarring of the bile ducts, both inside and outside the liver, leading to bile duct obstruction, which can result in cirrhosis, jaundice, and itching.

Fatty liver, also known as hepatic steatosis, is a condition in which there is an excessive build-up of fat in the liver. It can be caused by a variety of factors, including obesity, diabetes, and metabolic syndrome. This build-up of fat can occur in two forms, nonalcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). NAFLD is caused by a buildup of fat in the liver not caused by excessive alcohol consumption, while AFLD is caused by excessive alcohol consumption. Symptoms of fatty liver can include fatigue, abdominal pain, and weight loss, however, many people with the condition do not experience any symptoms. Left untreated, fatty liver can lead to more serious conditions such as cirrhosis and liver cancer. Treatment options for fatty liver include lifestyle changes such as diet and exercise, weight loss and medications. Associated Tests: Liver Function Maxi Lipid Profile Maxi

Patients date of birth, Height, Weight is must. Fasting Required Fibromax is a test that is used to assess the risk of fibrosis (or scarring) in the liver. Fibrosis is a common complication of chronic liver disease, and it can lead to cirrhosis and liver failure. The test is a non-invasive method that measures the levels of specific biomarkers in the blood, which can indicate the presence and severity of liver fibrosis. These biomarkers are produced by the liver when it is damaged and attempts to repair itself. The Fibromax test assesses the fibrosis activity by evaluating biochemicals like SGPT, SGOT, Triglycerides, Cholesterol, FBS, Bilirubin, Alpha 2 macroglobulin, Haptoglobulin, Apo A1, GGT and determines the cause of fibrosis. It can distinguish between steatohepatitis – alcoholic or nonalcoholic. Alcoholic steatohepatitis (ASH) is a type of liver disease that occurs in people who drink excessive amounts of alcohol. The liver becomes inflamed and filled with fat, leading to liver damage and scarring (cirrhosis). Nonalcoholic steatohepatitis (NASH) is a type of liver disease that occurs in people who do not drink excessive amounts of alcohol. Instead, it is characterized by the buildup of fat in the liver (steatosis), along with inflammation and liver cell damage. This can lead to cirrhosis. It is more common in individuals with risk factors such as obesity, metabolic syndrome, diabetes, and high triglycerides levels.